Published in Infect Immun on July 01, 1976
Immunological evaluation of a component isolated from Mycobacterium bovis BCG with a monoclonal antibody to M. bovis BCG. Infect Immun (1984) 3.46
A chemically synthesized peptide which elicits humoral and cellular immune responses to mycobacterial antigens. Infect Immun (1986) 1.13
Immunological method to differentiate between antigens of tubercle bacilli, other mycobacterial species, and non-acid-fast bacteria. Infect Immun (1978) 1.02
Mechanism of adjuvant activity of dental plaque: in vitro activation of residual helper T-cell precursors in T-cell-deficient murine spleen cell cultures. Infect Immun (1977) 0.82
A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol (1966) 43.66
Immunization of dissociated spleen cell cultures from normal mice. J Exp Med (1967) 30.93
Theta isoantigen as a marker of thymus-derived lymphocytes in mice. Nature (1969) 5.40
Immunopotentiation with BCG. II. Modulation of the response to sheep red blood cells. J Natl Cancer Inst (1973) 4.10
Immunopotentiation with BCG. I. Immune response to different strains and preparations. J Natl Cancer Inst (1973) 3.20
Water-soluble and lipid-free fraction from BCG with adjuvant and antitumour activity. Nat New Biol (1972) 1.70
A comparison of seven procedures to detect the primary binding of antigen by antibody. J Immunol (1969) 1.53
Requirement for bone marrow-derived cells in resistance to Listeria. J Immunol (1974) 1.40
Activation of lymphoid cells by BCG in vitro. Cell Immunol (1975) 1.38
Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma. J Natl Cancer Inst (1974) 1.38
Tumor suppression by cell walls of mycobacterium bovis attached to oil droplets. J Natl Cancer Inst (1972) 1.32
Binding between components of the tubercle bacillus and humoral antibodies. J Exp Med (1969) 1.31
Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells. J Natl Cancer Inst (1974) 1.17
Adjuvanticity of mycobacterial cell walls. Jpn J Microbiol (1971) 1.16
Immunopotentiation with BCG. 3. Modulation of the response to a tumor-specific antigen. J Natl Cancer Inst (1973) 1.01
Shared antigens between human malignant melanoma cells and Mycobacterium bovis (BCG). J Immunol (1976) 0.93
Some variable controls for accurate heterologous anti-immunoglobulin (HAI) tests. Immunochemistry (1975) 0.91
Modulation of the immune response by a methanol-insoluble fraction of attenuated tubercle bacilli (BCG). I. Primary and secondary responses to sheep red blood cells and T2 phage. Clin Exp Immunol (1970) 0.88
Prevention of tumor growth after intradermal injection of BCG extracts: a comparison of results in strain-2 guinea pigs from the National Institutes of Health and from the National Jewish Hospital and Research Center. J Natl Cancer Inst (1976) 0.81
Protection against guinea pig hepatomas by pretreatment with subcelluar fractions of Mycobacterium bovis (BCG). J Natl Cancer Inst (1974) 0.80
Biologically active components from mycobacterial cell walls. III. Production of experimental allergic encephalomyelitis in guinea-pigs. Immunology (1975) 0.79
Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol (1992) 11.24
Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol (1992) 3.79
Immunological evaluation of a component isolated from Mycobacterium bovis BCG with a monoclonal antibody to M. bovis BCG. Infect Immun (1984) 3.46
Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci U S A (1994) 3.24
Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history. Am Rev Respir Dis (1989) 3.08
Killing of Listeria monocytogenes by inflammatory neutrophils and mononuclear phagocytes from immune and nonimmune mice. J Leukoc Biol (1984) 3.02
An unusual lymphocytic perivascular infiltration in tissues around contemporary metal-on-metal joint replacements. J Bone Joint Surg Am (2005) 2.92
Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods (1994) 2.85
Correlation between inclination of the acetabular component and metal ion levels in metal-on-metal hip resurfacing replacement. J Bone Joint Surg Br (2008) 2.79
Revision of metal-on-metal resurfacing arthroplasty of the hip: the influence of malpositioning of the components. J Bone Joint Surg Br (2008) 2.28
Listeria cell wall fraction: a B cell mitogen. J Immunol (1975) 1.94
Gentamicin kills intracellular Listeria monocytogenes. Infect Immun (1994) 1.94
Macrophages as accessory cells for class I MHC-restricted immune responses. J Immunol (1991) 1.85
Metal ion measurement as a diagnostic tool to identify problems with metal-on-metal hip resurfacing. J Bone Joint Surg Am (2008) 1.85
Macrophage phagocytosis: use of fluorescence microscopy to distinguish between extracellular and intracellular bacteria. J Immunol Methods (1991) 1.83
Metal wear particle characterization from metal on metal total hip replacements: transmission electron microscopy study of periprosthetic tissues and isolated particles. J Biomed Mater Res (1998) 1.75
Listeria monocytogenes infects human endothelial cells by two distinct mechanisms. Infect Immun (1995) 1.68
Universal occurrence of antibodies to tubercle bacilli in sera from non-tuberculous and tuberculous individuals. Clin Exp Immunol (1973) 1.68
Tissue reaction to metal on metal total hip prostheses. Clin Orthop Relat Res (1996) 1.66
Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J Allergy Clin Immunol (1991) 1.65
Immune responses of human adults after oral and parenteral exposure to bovine serum albumin. J Allergy (1968) 1.65
Enhanced accumulation of inflammatory neutrophils and macrophages mediated by transfer of T cells from mice immunized with Listeria monocytogenes. J Immunol (1985) 1.64
Roles of complement and complement receptor type 3 in phagocytosis of Listeria monocytogenes by inflammatory mouse peritoneal macrophages. Infect Immun (1991) 1.55
Screening blood test identifies subclinical beryllium disease. J Occup Med (1989) 1.55
A comparison of seven procedures to detect the primary binding of antigen by antibody. J Immunol (1969) 1.53
Immunoreactivity of a 10-kDa antigen of Mycobacterium tuberculosis. J Immunol (1992) 1.52
Shared antigens between heterologous bacterial species. Infect Immun (1972) 1.50
Massive femoral osteolysis and early disintegration of a polyethylene-bearing surface of a total knee replacement. A case report. J Bone Joint Surg Am (1992) 1.48
Induction of Resistance by Listeria monocytogenes Cell Wall Fraction. Infect Immun (1974) 1.48
Precipitation of radiolabeled antigen-antibody complexes with protein A-containing Staphylococcus aureus. J Immunol (1977) 1.45
Prechemotherapy laparoscopic nephrectomy for Wilms' tumor. J Pediatr Urol (2009) 1.44
Listericidal and nonlistericidal mouse macrophages differ in complement receptor type 3-mediated phagocytosis of L. monocytogenes and in preventing escape of the bacteria into the cytoplasm. J Leukoc Biol (1992) 1.42
Shared antigens between Mycobacterium bovis (BCG) and other bacterial species. Science (1972) 1.41
Requirement for bone marrow-derived cells in resistance to Listeria. J Immunol (1974) 1.40
Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium. Arch Gen Psychiatry (1992) 1.40
Chemotaxigenesis and complement fixation by Listeria monocytogenes cell wall fractions. J Immunol (1977) 1.36
Notching of the femoral neck during resurfacing arthroplasty of the hip: a vascular study. J Bone Joint Surg Br (2006) 1.36
Genetically determined resistance to listeriosis is associated with increased accumulation of inflammatory neutrophils and macrophages which have enhanced listericidal activity. Immunology (1985) 1.35
Removal of immunoglobulin-bearing lymphocytes by anti-immunoglobulin-coated columns. Cell Immunol (1972) 1.32
Binding between components of the tubercle bacillus and humoral antibodies. J Exp Med (1969) 1.31
Immunocompetent cells in resistance to bacterial infections. Bacteriol Rev (1976) 1.31
Killing of Listeria monocytogenes by human neutrophils and monocytes, but not by monocyte-derived macrophages. J Reticuloendothel Soc (1983) 1.28
Role of transferrin, transferrin receptors, and iron in macrophage listericidal activity. J Exp Med (1991) 1.27
Mixing and matching causing taper wear: corrosion associated with pseudotumour formation. J Bone Joint Surg Br (2012) 1.19
Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells. J Natl Cancer Inst (1974) 1.17
Listeria cell wall fraction: a B cell adjuvant. J Immunol (1976) 1.16
Reduction of the potential for thermal damage during hip resurfacing. J Bone Joint Surg Br (2007) 1.15
Complement receptor type 3 (CD11b/CD18) involvement is essential for killing of Listeria monocytogenes by mouse macrophages. J Immunol (1993) 1.14
Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate. Clin Cancer Res (1996) 1.14
A chemically synthesized peptide which elicits humoral and cellular immune responses to mycobacterial antigens. Infect Immun (1986) 1.13
The newborn exstrophy bladder inadequate for primary closure: evaluation, management and outcome. J Urol (2001) 1.12
Quantitative assay for genus-specific leptospiral antigen and antibody. Appl Microbiol (1973) 1.12
Thioglycolate medium decreases resistance to bacterial infection in mice. Infect Immun (1980) 1.11
Chemical composition and biological functions of Listeria monocytogenes cell wall preparations. Infect Immun (1983) 1.09
Bone marrow cellular composition in Listeria monocytogenes infected mice detected using ER-MP12 and ER-MP20 antibodies: a flow cytometric alternative to differential counting. J Immunol Methods (1998) 1.07
Response of a gamma delta+ T cell receptor invariant subset during bacterial infection. J Immunol (1996) 1.07
TNF-alpha and IFN-gamma stimulate a macrophage precursor cell line to kill Listeria monocytogenes in a nitric oxide-independent manner. J Immunol (1994) 1.06
Psychopathic personality in children: genetic and environmental contributions. Psychol Med (2010) 1.03
Immune responses in rhesus monkeys after bacillus Calmette-Guerin vaccination and aerosol challenge with Mycobacterium tuberculosis. Am Rev Respir Dis (1973) 1.03
Phagocytosis and killing of Listeria monocytogenes by alveolar macrophages: smokers versus nonsmokers. J Infect Dis (1988) 1.03
Immunological method to differentiate between antigens of tubercle bacilli, other mycobacterial species, and non-acid-fast bacteria. Infect Immun (1978) 1.02
Fas (CD95) expression and death-mediating function are induced by CD4 cross-linking on CD4+ T cells. Proc Natl Acad Sci U S A (1996) 1.02
Metal versus polyethylene wear particles in total hip replacements. A review. Clin Orthop Relat Res (1996) 1.01
Multivariate models of mixed assortment: phenotypic assortment and social homogamy for education and fluid ability. Behav Genet (2000) 1.01
Cementless total joint arthroplasty prostheses with titanium-alloy articular surfaces. A human retrieval analysis. Clin Orthop Relat Res (1990) 1.00
Listeria cell wall fraction: adjuvant activity in vivo and in vitro. Cell Immunol (1975) 1.00
Immune complexes and antibodies to BCG in sera from patients with mycobacterial infections. Clin Exp Immunol (1980) 1.00
Wear particles from metal-on-metal total hip replacements: effects of implant design and implantation time. Proc Inst Mech Eng H (2006) 1.00
Cognitive abilities in reading-disabled children: a longitudinal study. J Child Psychol Psychiatry (1984) 0.98
False positive radio-immunoautograph lines associated with immunoglobulins from normal sera. J Immunol (1967) 0.98
Bone marrow-derived cells as target cells for polynucleotide adjuvants. J Immunol (1971) 0.98
Preparation and characterization of dendrimer-gold colloid nanocomposites. Anal Chem (1999) 0.97
A multicenter outcomes analysis of patients with neonatal reflux presenting with prenatal hydronephrosis. J Urol (1999) 0.97
Listericidal activity of human neutrophil cathepsin G. J Gen Microbiol (1990) 0.94
The contribution of frictional torque to loosening at the cement-bone interface in Tharies hip replacements. J Bone Joint Surg Am (1996) 0.94
Differential expression of macrophage effector functions: bactericidal versus tumoricidal activities. J Leukoc Biol (1984) 0.93
Shared antigens between human malignant melanoma cells and Mycobacterium bovis (BCG). J Immunol (1976) 0.93
Obesity and decreased femoral anteversion in adolescence. J Orthop Res (1987) 0.93
Differentiation of antibody-forming cells. I. Ratio of precursor cells to antibody-forming cells in the mouse spleen. J Immunol (1968) 0.92
Interleukin-4 is chemotactic for mouse macrophages. Cell Immunol (1992) 0.92
Listeria cell wall fraction. Characterization of in vitro adjuvant activity. Immunology (1976) 0.92
Some variable controls for accurate heterologous anti-immunoglobulin (HAI) tests. Immunochemistry (1975) 0.91
Heterogeneity of antibodies produced by single hemolytic foci. Cell Immunol (1971) 0.90
An [35S]methionine cytotoxicity assay requiring small numbers of effector and target cells. J Immunol Methods (1989) 0.89
Use of a macrophage cytotoxicity system to show macrophage activation by Listeria monocytogenes cell wall fraction. Scand J Immunol (1979) 0.89
Internalin A can mediate phagocytosis of Listeria monocytogenes by mouse macrophage cell lines. J Leukoc Biol (1996) 0.89
Some macrophages kill Listeria monocytogenes while others do not. Immunol Rev (1997) 0.89
Precision-fit surface hemiarthroplasty for femoral head osteonecrosis. Long-term results. J Bone Joint Surg Br (1994) 0.89
Vitamin E enhances in vitro immune response by normal and nonadherent spleen cells. Proc Soc Exp Biol Med (1974) 0.89
Silica decreases phagocytosis and bactericidal activity of both macrophages and neutrophils in vitro. Immunology (1986) 0.88
Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin. Cancer Res (1980) 0.88
Reaginic activity associated with IgG immunoglobulin. J Exp Med (1966) 0.88
Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity. Int J Oncol (2000) 0.88
A solid-phase radioimmunoassay to detect antibodies produced by hybridomas to antigens derived from human melanoma cells. Cancer Immunol Immunother (1983) 0.88
Methodology for long-term wear testing of total knee replacements. Clin Orthop Relat Res (2000) 0.87
Plaque-forming cells of two different origins in single hemolytic foci. J Immunol (1970) 0.87
Factors contributing to rapid wear and osteolysis in hips with modular acetabular bearings made of hylamer. J Arthroplasty (2000) 0.87